drugset / Trial / NCT02494466

Preoperative Use of Montelukast Sodium

NCT02494466

Phase 4 Completed 30 enrolled Umraniye Education and Research Hospital
RandomizedCrossoverSingle-blindPrevention

Summary

Supraglottic airway equipment used during anaesthesia application can lead to airway reactivity or even larynx spasm in sensitive children. Montelukast Sodium, used in asthma treatment, is a cysteinyl leukotriene Type 1 antagonist which reduces leukotriene C4, leukotriene D4 and leukotriene E4 synthesis. The use of Montelukast Sodium in airway reactivity is known to reduce the need for bronchodilator and corticosteroids.

Timeline

Start
2014-05
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 4 mg Oral